Trgovina Kaleido Biosciences, Inc. - KLDO CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.05 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ključni statistični podatki
| Predhodno. Zapri* | 0.39 |
| Odpri* | 0.4 |
| Enoletna sprememba* | 2.56% |
| Dnevni razpon* | 0.38 - 0.45 |
| Razpon 52 wk | 0.00-1.92 |
| Povprečni obseg (10 dni) | 26.79K |
| Povprečni obseg (3 meseci) | 306.37K |
| Tržna kapitalizacija | 8,520.00 |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 42.62M |
| Prihodki | 1.10M |
| EPS | -2.16 |
| Dividenda (donosnost v %) | N/A |
| Beta | 0.47 |
| Datum naslednjega zaslužka | Mar 23, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Apr 14, 2022 | 0.38 | 0.00 | 0.00% | 0.38 | 0.38 | 0.38 |
| Apr 13, 2022 | 0.39 | 0.00 | 0.00% | 0.39 | 0.47 | 0.38 |
| Apr 8, 2022 | 0.40 | -0.24 | -37.50% | 0.64 | 0.64 | 0.38 |
| Apr 7, 2022 | 1.46 | -0.01 | -0.68% | 1.47 | 1.55 | 1.42 |
| Apr 6, 2022 | 1.46 | -0.02 | -1.35% | 1.48 | 1.48 | 1.42 |
| Apr 5, 2022 | 1.50 | -0.09 | -5.66% | 1.59 | 1.62 | 1.48 |
| Apr 4, 2022 | 1.59 | -0.14 | -8.09% | 1.73 | 1.73 | 1.54 |
| Apr 1, 2022 | 1.68 | 0.06 | 3.70% | 1.62 | 1.70 | 1.58 |
| Mar 31, 2022 | 1.60 | -0.08 | -4.76% | 1.68 | 1.72 | 1.55 |
| Mar 30, 2022 | 1.69 | -0.14 | -7.65% | 1.83 | 1.83 | 1.69 |
| Mar 29, 2022 | 1.70 | 0.02 | 1.19% | 1.68 | 1.77 | 1.60 |
| Mar 28, 2022 | 1.60 | -0.13 | -7.51% | 1.73 | 1.73 | 1.50 |
| Mar 25, 2022 | 1.64 | -0.10 | -5.75% | 1.74 | 1.74 | 1.63 |
| Mar 24, 2022 | 1.74 | 0.00 | 0.00% | 1.74 | 1.76 | 1.68 |
| Mar 23, 2022 | 1.74 | 0.01 | 0.58% | 1.73 | 1.81 | 1.73 |
| Mar 22, 2022 | 1.75 | 0.10 | 6.06% | 1.65 | 1.75 | 1.65 |
| Mar 21, 2022 | 1.63 | -0.05 | -2.98% | 1.68 | 1.68 | 1.55 |
| Mar 18, 2022 | 1.67 | 0.14 | 9.15% | 1.53 | 1.71 | 1.53 |
| Mar 17, 2022 | 1.56 | 0.14 | 9.86% | 1.42 | 1.57 | 1.42 |
| Mar 16, 2022 | 1.42 | 0.04 | 2.90% | 1.38 | 1.42 | 1.31 |
Kaleido Biosciences, Inc. Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Skupni prihodki | 1.104 | 0.975 | 0 | 0 | 0 |
| Celotni odhodki iz poslovanja | 88.771 | 79.849 | 87.24 | 60.683 | 27.03 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 20.968 | 23.882 | 22.428 | 18.621 | 6.038 |
| Raziskave in razvoj | 67.803 | 55.967 | 64.232 | 42.062 | 20.992 |
| Prihodki iz poslovanja | -87.667 | -78.874 | -87.24 | -60.683 | -27.03 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -2.766 | -2.553 | 0.968 | -0.805 | -0.512 |
| Drugo, neto | 0.145 | -0.193 | -0.059 | -0.256 | -0.017 |
| Čisti dobiček pred obdavčitvijo | -90.288 | -81.62 | -86.331 | -61.744 | -27.559 |
| Čisti dobiček po davkih | -90.288 | -81.62 | -86.331 | -61.744 | -27.559 |
| Čisti dobiček pred dodatnimi postavkami | -90.288 | -81.62 | -86.331 | -61.744 | -27.559 |
| Čisti dobiček | -90.288 | -81.62 | -86.331 | -61.744 | -27.559 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -90.288 | -81.62 | -86.331 | -61.744 | -27.559 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -90.288 | -81.62 | -86.331 | -61.744 | -27.559 |
| Popravljen čisti dobiček | -90.288 | -81.62 | -86.331 | -61.744 | -27.559 |
| Popravljene ponderirane povprečne delnice | 41.86 | 33.4502 | 25.7033 | 29.3948 | 29.3948 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -2.1569 | -2.44004 | -3.35876 | -2.10051 | -0.93755 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
| Popravljen normalizirani dobiček na enoto čistega dobička | -2.1569 | -2.44004 | -3.33619 | -2.10051 | -0.93755 |
| Nenavadni odhodki (prihodki) | 0 | 0.58 | |||
| Prihodki | 1.104 | 0.975 |
| Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | |
|---|---|---|---|---|---|
| Skupni prihodki | 0.492 | 0.104 | 0.211 | 0.297 | 0.243 |
| Prihodki | 0.492 | 0.104 | 0.211 | 0.297 | 0.243 |
| Celotni odhodki iz poslovanja | 20.191 | 22.517 | 23.418 | 22.645 | 19.543 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 4.617 | 5.106 | 5.785 | 5.46 | 5.205 |
| Raziskave in razvoj | 15.574 | 17.411 | 17.633 | 17.185 | 14.338 |
| Nenavadni odhodki (prihodki) | 0 | ||||
| Prihodki iz poslovanja | -19.699 | -22.413 | -23.207 | -22.348 | -19.3 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -0.705 | -0.692 | -0.681 | -0.688 | -0.713 |
| Drugo, neto | 0.132 | 0.02 | -0.001 | -0.006 | -0.003 |
| Čisti dobiček pred obdavčitvijo | -20.272 | -23.085 | -23.889 | -23.042 | -20.016 |
| Čisti dobiček po davkih | -20.272 | -23.085 | -23.889 | -23.042 | -20.016 |
| Čisti dobiček pred dodatnimi postavkami | -20.272 | -23.085 | -23.889 | -23.042 | -20.016 |
| Čisti dobiček | -20.272 | -23.085 | -23.889 | -23.042 | -20.016 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -20.272 | -23.085 | -23.889 | -23.042 | -20.016 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -20.272 | -23.085 | -23.889 | -23.042 | -20.016 |
| Popravljen čisti dobiček | -20.272 | -23.085 | -23.889 | -23.042 | -20.016 |
| Popravljene ponderirane povprečne delnice | 42.5995 | 42.5776 | 42.5386 | 39.6926 | 35.9841 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.47587 | -0.54219 | -0.56158 | -0.58051 | -0.55625 |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.47587 | -0.54219 | -0.56158 | -0.58051 | -0.55625 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 42.311 | 48.721 | 73.279 | 76.243 | 28.551 |
| Denarna sredstva in kratkoročne naložbe | 38.474 | 46.222 | 71.241 | 76.086 | 28.456 |
| Denarna sredstva in ustrezniki | 38.474 | 46.222 | 71.241 | 76.086 | 28.456 |
| Celotne terjatve, neto | 0.005 | 0.045 | |||
| Prepaid Expenses | 3.583 | 2.499 | 2.038 | 0.152 | 0.05 |
| Total Assets | 50.137 | 59.344 | 82.306 | 85.325 | 30.747 |
| Property/Plant/Equipment, Total - Net | 5.665 | 8.462 | 6.742 | 4.693 | 1.975 |
| Property/Plant/Equipment, Total - Gross | 11.136 | 11.955 | 9.281 | 5.914 | 2.406 |
| Accumulated Depreciation, Total | -5.471 | -3.493 | -2.539 | -1.221 | -0.431 |
| Other Long Term Assets, Total | 2.161 | 2.161 | 2.285 | 4.389 | 0.221 |
| Total Current Liabilities | 29.682 | 16.659 | 10.377 | 11.301 | 3.854 |
| Accounts Payable | 5.67 | 5.389 | 2.016 | 3.442 | 0.864 |
| Accrued Expenses | 6.686 | 7.356 | 7.086 | 7.406 | 2.615 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 16.144 | 2.634 | 0.068 | 0.091 | 0.104 |
| Other Current Liabilities, Total | 1.182 | 1.28 | 1.207 | 0.362 | 0.271 |
| Total Liabilities | 39.53 | 38.848 | 33.423 | 28.343 | 21.932 |
| Total Long Term Debt | 5.55 | 18.375 | 20.391 | 14.831 | 14.81 |
| Long Term Debt | 5.55 | 18.375 | 20.391 | 14.831 | 14.81 |
| Other Liabilities, Total | 4.298 | 3.814 | 2.655 | 2.211 | 3.268 |
| Total Equity | 10.607 | 20.496 | 48.883 | 56.982 | 8.815 |
| Preferred Stock - Non Redeemable, Net | 153.226 | 52.494 | |||
| Common Stock | 0.043 | 0.036 | 0.03 | 0.006 | 0.005 |
| Additional Paid-In Capital | 375.031 | 294.639 | 241.412 | 9.978 | 0.8 |
| Retained Earnings (Accumulated Deficit) | -364.467 | -274.179 | -192.559 | -106.228 | -44.484 |
| Total Liabilities & Shareholders’ Equity | 50.137 | 59.344 | 82.306 | 85.325 | 30.747 |
| Total Common Shares Outstanding | 42.596 | 36.0228 | 30.1278 | 29.3948 | 29.3948 |
| Redeemable Preferred Stock | 0 | 0 | |||
| Other Current Assets, Total | 0.254 |
| Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 42.311 | 58.304 | 74.603 | 95.032 | 48.721 |
| Denarna sredstva in kratkoročne naložbe | 38.474 | 55.657 | 71.979 | 92.362 | 46.222 |
| Denarna sredstva in ustrezniki | 38.474 | 55.657 | 71.979 | 92.362 | 46.222 |
| Prepaid Expenses | 3.583 | 2.647 | 2.624 | 2.67 | 2.499 |
| Total Assets | 50.137 | 67.804 | 84.29 | 105.026 | 59.344 |
| Property/Plant/Equipment, Total - Net | 5.665 | 7.339 | 7.526 | 7.833 | 8.462 |
| Property/Plant/Equipment, Total - Gross | 11.136 | 12.482 | 12.165 | 11.889 | 11.955 |
| Accumulated Depreciation, Total | -5.471 | -5.143 | -4.639 | -4.056 | -3.493 |
| Other Long Term Assets, Total | 2.161 | 2.161 | 2.161 | 2.161 | 2.161 |
| Total Current Liabilities | 29.682 | 19.261 | 12.269 | 12.873 | 16.659 |
| Accounts Payable | 5.67 | 3.559 | 2.695 | 2.412 | 5.389 |
| Accrued Expenses | 6.686 | 8.681 | 5.014 | 4.403 | 7.356 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 16.144 | 6.384 | 3.667 | 4.759 | 2.634 |
| Other Current Liabilities, Total | 1.182 | 0.637 | 0.893 | 1.299 | 1.28 |
| Total Liabilities | 39.53 | 38.604 | 34.024 | 33.252 | 38.848 |
| Total Long Term Debt | 5.55 | 15.132 | 17.677 | 16.433 | 18.375 |
| Long Term Debt | 5.55 | 15.132 | 17.677 | 16.433 | 18.375 |
| Other Liabilities, Total | 4.298 | 4.211 | 4.078 | 3.946 | 3.814 |
| Total Equity | 10.607 | 29.2 | 50.266 | 71.774 | 20.496 |
| Common Stock | 0.043 | 0.043 | 0.043 | 0.042 | 0.036 |
| Additional Paid-In Capital | 375.031 | 373.352 | 371.333 | 368.953 | 294.639 |
| Retained Earnings (Accumulated Deficit) | -364.467 | -344.195 | -321.11 | -297.221 | -274.179 |
| Total Liabilities & Shareholders’ Equity | 50.137 | 67.804 | 84.29 | 105.026 | 59.344 |
| Total Common Shares Outstanding | 42.596 | 42.5801 | 42.5714 | 42.4832 | 36.0228 |
| Redeemable Preferred Stock | 0 | 0 | |||
| Other Current Assets, Total | 0.254 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -90.288 | -81.62 | -86.331 | -61.744 | -27.559 |
| Denarna sredstva iz poslovanja | -77.094 | -61.518 | -75.796 | -46.316 | -22.495 |
| Denarna sredstva iz poslovanja | 2.358 | 1.823 | 1.318 | 0.792 | 0.316 |
| Nedenarne postavke | 11.099 | 13.728 | 10.433 | 8.14 | 0.738 |
| Denarna sredstva Plačane obresti | 2.133 | 1.925 | 0.881 | 0.943 | 0.343 |
| Spremembe v obratnem kapitalu | -0.263 | 4.551 | -1.216 | 6.496 | 4.01 |
| Denarna sredstva pri naložbenju | -0.691 | -4.024 | -3.586 | -3.002 | -1.406 |
| Kapitalski izdatki | -1.129 | -4.024 | -3.586 | -3.002 | -1.406 |
| Denarna sredstva pri financiranju | 70.037 | 40.399 | 74.642 | 98.907 | 49.736 |
| Postavke denarnega toka pri financiranju | -0.359 | -0.079 | -1.158 | -1.84 | 0 |
| Izdaja (odplačilo) delnic, neto | 70.396 | 40.546 | 68.391 | 100.852 | 39.86 |
| Izdaja (odplačilo) dolga, neto | 0 | -0.068 | 7.409 | -0.105 | 9.876 |
| Neto sprememba denarnih sredstev | -7.748 | -25.143 | -4.74 | 49.589 | 25.835 |
| Celotne druge postavke denarnih tokov pri naložbenju | 0.438 |
| Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -90.288 | -70.016 | -46.931 | -23.042 | -81.62 |
| Cash From Operating Activities | -77.094 | -59.934 | -44.057 | -23.974 | -61.518 |
| Cash From Operating Activities | 2.358 | 1.754 | 1.16 | 0.577 | 1.823 |
| Non-Cash Items | 11.099 | 9.331 | 7.146 | 4.603 | 13.728 |
| Cash Interest Paid | 2.133 | 1.601 | 1.064 | 0.526 | 1.925 |
| Changes in Working Capital | -0.263 | -1.003 | -5.432 | -6.112 | 4.551 |
| Cash From Investing Activities | -0.691 | -0.693 | -0.262 | -0.03 | -4.024 |
| Capital Expenditures | -1.129 | -0.693 | -0.262 | -0.03 | -4.024 |
| Cash From Financing Activities | 70.037 | 70.062 | 70.076 | 70.144 | 40.399 |
| Financing Cash Flow Items | -0.359 | -0.329 | -0.31 | -0.186 | -0.079 |
| Issuance (Retirement) of Stock, Net | 70.396 | 70.391 | 70.386 | 70.33 | 40.546 |
| Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | -0.068 | |
| Net Change in Cash | -7.748 | 9.435 | 25.757 | 46.14 | -25.143 |
| Other Investing Cash Flow Items, Total | 0.438 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| Menichella (Daniel L.) | Individual Investor | 0.2996 | 127700 | 107700 | 2022-03-31 | MED |
| Duke (William E. Jr.) | Individual Investor | 0.1598 | 68115 | 68115 | 2022-03-31 | LOW |
| Korn (Jerald) | Individual Investor | 0.1215 | 51803 | 51803 | 2022-03-31 | |
| Melas-Kyriazi (Theo) | Individual Investor | 0.0782 | 33333 | 0 | 2022-03-31 | LOW |
| Quinn (Anthony G) | Individual Investor | 0.0741 | 31603 | 0 | 2022-03-31 | LOW |
| Northern Trust Global Investments | Investment Advisor | 0.0334 | 14235 | 14235 | 2022-12-31 | LOW |
| DWS Investments UK Limited | Investment Advisor | 0.0244 | 10387 | 0 | 2023-02-28 | MED |
| Amalgamated Financial Corp. | Investment Advisor | 0.0077 | 3266 | 3266 | 2022-03-31 | |
| Mackenzie Financial Corporation | Investment Advisor/Hedge Fund | 0.0027 | 1139 | -148 | 2022-09-30 | LOW |
| Westfield Capital Management Company, L.P. | Investment Advisor/Hedge Fund | 0.002 | 854 | 0 | 2021-09-30 | LOW |
| Carroll Financial Associates, Inc. | Investment Advisor | 0.0008 | 339 | 0 | 2021-12-31 |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Kaleido Biosciences, Inc. Company profile
O družbi Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. je zdravstveno podjetje na klinični stopnji, ki se osredotoča na izkoriščanje potenciala mikrobioma za zdravljenje bolezni in izboljšanje zdravja ljudi. Njegovo zdravilo Microbiome Metabolic Therapies (MMT) je namenjeno spodbujanju delovanja in porazdelitve obstoječih mikrobov, da bi zmanjšalo ali povečalo proizvodnjo metabolitov za določene bakterije v skupnosti mikrobioma. Družba razvija tudi širok nabor kandidatov za MMT, ki lahko obravnavajo različne bolezni in stanja z neizpolnjenimi potrebami bolnikov. Družba uporablja svojo platformo za odkrivanje in razvoj za preučevanje MMT v vzorcih mikrobioma za hitro napredovanje kandidatov za MMT v klinične študije na zdravih osebah in bolnikih. KB195 je vodilni kandidat za MMT za razvoj pri zdravljenju bolnikov z motnjami cikla sečnine. Družba izvaja klinično preskušanje faze II na podlagi vloge za novo raziskovalno zdravilo (IND).
| Industry: | Biotechnology & Medical Research (NEC) |
18 Crosby Dr
BEDFORD
MASSACHUSETTS 01730-1402
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com